Literature DB >> 28287583

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation.

Lucas Tricoli1, Deborah L Berry2, Chris Albanese3.   

Abstract

Conditionally reprogrammed cells (CRCs) provide a sustainable method for primary cell culture and the ability to develop extensive "living biobanks" of patient derived cell lines. For many types of epithelial cells, various three dimensional (3D) culture approaches have been described that support an improved differentiated state. While CRCs retain their lineage commitment to the tissue from which they are isolated, they fail to express many of the differentiation markers associated with the tissue of origin when grown under normal two dimensional (2D) culture conditions. To enhance the application of patient-derived CRCs for prostate cancer research, a 3D culture format has been defined that enables a rapid (2 weeks total) luminal cell differentiation in both normal and tumor-derived prostate epithelial cells. Herein, a filter insert-based format is described for the culturing and differentiation of both normal and malignant prostate CRCs. A detailed description of the procedures required for cell collection and processing for immunohistochemical and immunofluorescent staining are provided. Collectively the 3D culture format described, combined with the primary CRC lines, provides an important medium- to high- throughput model system for biospecimen-based prostate research.

Entities:  

Mesh:

Year:  2017        PMID: 28287583      PMCID: PMC5408911          DOI: 10.3791/55279

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells.

Authors:  Nancy Palechor-Ceron; Frank A Suprynowicz; Geeta Upadhyay; Aleksandra Dakic; Tsion Minas; Vera Simic; Michael Johnson; Christopher Albanese; Richard Schlegel; Xuefeng Liu
Journal:  Am J Pathol       Date:  2013-10-03       Impact factor: 4.307

2.  Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer.

Authors:  Khalid Saeed; Vesa Rahkama; Samuli Eldfors; Dmitry Bychkov; John Patrick Mpindi; Bhagwan Yadav; Lassi Paavolainen; Tero Aittokallio; Caroline Heckman; Krister Wennerberg; Donna M Peehl; Peter Horvath; Tuomas Mirtti; Antti Rannikko; Olli Kallioniemi; Päivi Östling; Taija M Af Hällström
Journal:  Eur Urol       Date:  2016-05-06       Impact factor: 20.096

3.  p63 is a prostate basal cell marker and is required for prostate development.

Authors:  S Signoretti; D Waltregny; J Dilks; B Isaac; D Lin; L Garraway; A Yang; R Montironi; F McKeon; M Loda
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Use of reprogrammed cells to identify therapy for respiratory papillomatosis.

Authors:  Hang Yuan; Scott Myers; Jingang Wang; Dan Zhou; Jennifer A Woo; Bhaskar Kallakury; Andrew Ju; Michael Bazylewicz; Yvonne M Carter; Christopher Albanese; Nazaneen Grant; Aziza Shad; Anatoly Dritschilo; Xuefeng Liu; Richard Schlegel
Journal:  N Engl J Med       Date:  2012-09-27       Impact factor: 91.245

5.  Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor.

Authors:  Sandra Chapman; Xuefeng Liu; Craig Meyers; Richard Schlegel; Alison A McBride
Journal:  J Clin Invest       Date:  2010-07       Impact factor: 14.808

6.  Organoid cultures derived from patients with advanced prostate cancer.

Authors:  Dong Gao; Ian Vela; Andrea Sboner; Phillip J Iaquinta; Wouter R Karthaus; Anuradha Gopalan; Catherine Dowling; Jackline N Wanjala; Eva A Undvall; Vivek K Arora; John Wongvipat; Myriam Kossai; Sinan Ramazanoglu; Luendreo P Barboza; Wei Di; Zhen Cao; Qi Fan Zhang; Inna Sirota; Leili Ran; Theresa Y MacDonald; Himisha Beltran; Juan-Miguel Mosquera; Karim A Touijer; Peter T Scardino; Vincent P Laudone; Kristen R Curtis; Dana E Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Stephen B Solomon; James A Eastham; Ping Chi; Brett Carver; Mark A Rubin; Howard I Scher; Hans Clevers; Charles L Sawyers; Yu Chen
Journal:  Cell       Date:  2014-09-04       Impact factor: 41.582

Review 7.  Patient-derived xenograft models: an emerging platform for translational cancer research.

Authors:  Manuel Hidalgo; Frederic Amant; Andrew V Biankin; Eva Budinská; Annette T Byrne; Carlos Caldas; Robert B Clarke; Steven de Jong; Jos Jonkers; Gunhild Mari Mælandsmo; Sergio Roman-Roman; Joan Seoane; Livio Trusolino; Alberto Villanueva
Journal:  Cancer Discov       Date:  2014-07-15       Impact factor: 39.397

8.  The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.

Authors:  Lymor Ringer; Paul Sirajuddin; Lucas Tricoli; Sarah Waye; Muhammad Umer Choudhry; Erika Parasido; Angiela Sivakumar; Mary Heckler; Aisha Naeem; Iman Abdelgawad; Xuefeng Liu; Adam S Feldman; Richard J Lee; Chin-Lee Wu; Venkata Yenugonda; Bhaskar Kallakury; Anatoly Dritschilo; John Lynch; Richard Schlegel; Olga Rodriguez; Richard G Pestell; Maria Laura Avantaggiati; Chris Albanese
Journal:  Oncotarget       Date:  2014-11-15

9.  Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair.

Authors:  Michael P Croglio; Jefferson M Haake; Colin P Ryan; Victor S Wang; Jennifer Lapier; Jamie P Schlarbaum; Yaron Dayani; Emma Artuso; Cristina Prandi; Hinanit Koltai; Keli Agama; Yves Pommier; Yu Chen; Lucas Tricoli; Jeannine R LaRocque; Christopher Albanese; Ronit I Yarden
Journal:  Oncotarget       Date:  2016-03-22

10.  Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.

Authors:  Claire B Pollock; Sara McDonough; Victor S Wang; Hyojung Lee; Lymor Ringer; Xin Li; Cristina Prandi; Richard J Lee; Adam S Feldman; Hinanit Koltai; Yoram Kapulnik; Olga C Rodriguez; Richard Schlegel; Christopher Albanese; Ronit I Yarden
Journal:  Oncotarget       Date:  2014-03-30
View more
  2 in total

1.  Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer.

Authors:  Saba Choudhary; Poornema Ramasundaram; Eugenia Dziopa; Ciaran Mannion; Yair Kissin; Lucas Tricoli; Christopher Albanese; Woo Lee; Jenny Zilberberg
Journal:  Sci Rep       Date:  2018-12-19       Impact factor: 4.379

2.  Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells.

Authors:  Lucas Tricoli; Aisha Naeem; Erika Parasido; John P Mikhaiel; Muhammad Umer Choudhry; Deborah L Berry; Iman A Abdelgawad; Richard J Lee; Adam S Feldman; Chukwuemeka Ihemelandu; Maria Avantaggiati; Deepak Kumar; Stephen Byers; Rosa Gallagher; Julia Wulfkuhle; Emanuel Petricoin; Olga Rodriguez; Chris Albanese
Journal:  Oncotarget       Date:  2017-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.